Supply chain snags, product recalls and runaway inflation have made it very difficult to find baby formula in the United States.
Abbott Laboratories said on Wednesday it could restart production of infant formula at its troubled Michigan facility within two weeks.
The company in February recalled some baby formulas, including certain Similac products, made at the plant in Sturgis after complaints about bacterial infections in infants who had consumed the products.
The news comes a day after United States retailers including Target Corp, CVS Health Corp and Walgreens Boots Alliance said they have limited purchases of infant formula due to a supply shortage.
Abbott will restart production of EleCare, Alimentum and metabolic formulas first, followed by Similac and other brands, after receiving the go-ahead from the US Food & Drug Administration (FDA).
Once production is resumed, it will take six to eight weeks before the product returns to shelves.
Abbott is the leading supplier
..... (Read more by following the post link below)